X
PFE icon

Xponance’s Pfizer PFE Stock Holding History

Xponance’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.7M Buy
1,108,420
+24,630
+2% +$644K 0.16% 92
2026
Q1 		$30.4M Buy
1,083,790
+131,534
+14% +$3.5M 0.22% 74
2025
Q4 		$23.7M Buy
952,256
+77,679
+9% +$1.96M 0.18% 87
2025
Q3 		$22.3M Sell
874,577
-25,024
-3% -$618K 0.18% 89
2025
Q2 		$21.8M Buy
899,601
+44,732
+5% +$1.04M 0.18% 88
2025
Q1 		$21.7M Buy
854,869
+3,621
+0.4% +$94.8K 0.21% 81
2024
Q4 		$22.6M Buy
851,248
+34,344
+4% +$932K 0.21% 69
2024
Q3 		$23.6M Sell
816,904
-71,728
-8% -$2.09M 0.23% 70
2024
Q2 		$24.9M Sell
888,632
-50,202
-5% -$1.38M 0.25% 56
2024
Q1 		$26.1M Buy
938,834
+47,810
+5% +$1.33M 0.27% 60
2023
Q4 		$25.7M Buy
891,024
+91,843
+11% +$2.78M 0.31% 53
2023
Q3 		$26.5M Buy
799,181
+61,069
+8% +$2.16M 0.36% 41
2023
Q2 		$27.1M Buy
738,112
+335
+0% +$13K 0.36% 40
2023
Q1 		$30.1M Buy
737,777
+37,525
+5% +$1.62M 0.44% 35
2022
Q4 		$35.9M Buy
700,252
+102,024
+17% +$4.89M 0.58% 27
2022
Q3 		$26.2M Buy
598,228
+81,844
+16% +$3.98M 0.5% 28
2022
Q2 		$27.1M Sell
516,384
-11,845
-2% -$604K 0.54% 28
2022
Q1 		$27.3M Buy
528,229
+7,091
+1% +$368K 0.45% 33
2021
Q4 		$30.8M Buy
521,138
+105,259
+25% +$5.22M 0.48% 33
2021
Q3 		$17.9M Sell
415,879
-27,461
-6% -$1.22M 0.34% 56
2021
Q2 		$17.4M Sell
443,340
-42,975
-9% -$1.67M 0.32% 62
2021
Q1 		$17.6M Buy
486,315
+996
+0.2% +$35.4K 0.37% 50
2020
Q4 		$17.9M Sell
485,319
-20,194
-4% -$741K 0.39% 47
2020
Q3 		$17.6M Sell
505,513
-58,255
-10% -$2.04M 0.43% 44
2020
Q2 		$17.5M Buy
+563,768
New +$19.2M 0.45% 43

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Xponance's PFE Position: Q2 2026 in Review

Xponance increased its Pfizer (PFE) stake by 2.3% in Q2 2026, buying an estimated $644K and bringing the position to 1,108,420 shares worth $26.7M. The position accounts for 0.16% of the portfolio, ranked #92.

Xponance first reported a position in PFE in Q2 2020 and has held it in 25 quarters since. The position peaked at $35.9M in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Xponance held 1,108,420 shares of Pfizer worth $26.7M as of Q2 2026.
  • Xponance bought 24,630 Pfizer shares in Q2 2026, an estimated $644K.
  • Pfizer made up 0.16% of Xponance's portfolio in Q2 2026, its #92 holding.
  • Xponance first reported a position in Pfizer in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Pfizer position peaked at $35.9M in Q4 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.